| Angela Baird, CMHC | |
|
800 W University Pkwy, Orem, UT 84058-6703 | |
| (801) 863-4780 | |
| Not Available |
| Full Name | Angela Baird |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 800 W University Pkwy, Orem, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093568396 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Angela Baird, CMHC 672 E Perry Hollow Dr, Mapleton, UT 84664-5576 Ph: (801) 634-1093 | Angela Baird, CMHC 800 W University Pkwy, Orem, UT 84058-6703 Ph: (801) 863-4780 |
News Archive
A new study reveals that a common underlying mechanism is shared by a group of previously unrelated disorders which all cause complex defects in brain development and function. Rett syndrome (RTT), Cornelia de Lange syndrome (CdLS) and Alpha-Thalassemia mental Retardation, X-linked syndrome (ATR-X) have each been linked with distinct abnormalities in chromatin, the spools of proteins and DNA that make up chromosomes and control how genetic information is read in a cell.
The largest study ever of breast cancer in Latin American women is being launched this year in a unique multi-country, public/private partnership with $1 million in additional funding from the world's largest breast cancer organization, Susan G. Komen for the Cure®.
Neovasc Inc., a developer of novel technologies used to treat vascular disease, today announced that the first patients have been enrolled in its COSIRA trial designed to assess the clinical efficacy of the Neovasc Reducer(TM) product for the treatment of refractory angina. The COSIRA (Coronary Sinus Reducer for Treatment of Refractory Angina) trial is a multicenter, sham-controlled, randomized, double-blinded study of the Reducer that is expected to enroll up to 124 patients.
Targeted Genetics Corporation (the "Company") today announced that it has determined that the expense and management attention required for NASDAQ Capital Market and Securities and Exchange Commission ("SEC") compliance outweigh the benefits for the Company and its shareholders at this time.
To commemorate World TB Day, a Special Collection has been released by PLOS Medicine containing a series of articles that articulate the essential new steps in clinical research that will pave the way for the development of tomorrow's optimal treatment for all forms of tuberculosis.
› Verified 1 days ago
Mr. Joseph Darren Allred, LAPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1255 N 1200 W, Orem, UT 84057 Phone: 801-229-1181 | |
Abraham Hudson, ACMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 853 W Center St, Orem, UT 84057 Phone: 801-358-4463 | |
Archie Dee Egbert, CMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 359 E 1200 S, Orem, UT 84058 Phone: 801-921-1200 | |
Carlene A Crane, MS, ACMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 165 N 1330 W Ste A1, Orem, UT 84057 Phone: 801-960-3040 | |
Sabra Mary Dixon, LSUDC Counselor Medicare: Not Enrolled in Medicare Practice Location: 591 W 800 N, Orem, UT 84057 Phone: 801-427-9726 | |
Gerald Baird, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1790 N State St, Orem, UT 84057 Phone: 888-224-8250 | |
Jessica Wyly, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1159 N 1165 W, Orem, UT 84057 Phone: 801-389-2381 |